Merrimack Pharmaceuticals, Inc. (MACK) SEC filings
MACK SEC filings moved a median of -0.03% by the close. MACK SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MACK overview →
21 measured MACK SEC filing events.
Where these MACK SEC filings landedvs 20 measured MACK SEC filing reactions
| Middle 50% of MACK SEC filing reactions | -0.13% to +0.20% |
|---|---|
| Median reaction (to close) | -0.03% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 MACK SEC filing events with a measured close landed between -0.13% and +0.20%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G MERRIMACK PHARMACEUTICAL | SEC filing · Form 15-12G | — | — | |
| Form 10-Q MERRIMACK PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -0.10% | -0.07% | |
| Form 25 MERRIMACK PHARMACEUTICAL | SEC filing · Form 25 | +0.10% | -0.07% | |
| Form 8-K MERRIMACK PHARMACEUTICAL For: May 10 | SEC filing · Form 8-K | +0.10% | -0.07% | |
| Form 8-K MERRIMACK PHARMACEUTICAL For: May 08 | SEC filing · Form 8-K | +0.00% | -0.13% | |
| Form DEFA14A MERRIMACK PHARMACEUTICAL | SEC filing · Form DEFA14A | +0.00% | -0.13% | |
| Form 8-K MERRIMACK PHARMACEUTICAL For: Apr 30 | SEC filing · Form 8-K | +0.07% | +0.20% | |
| Form DEFA14A MERRIMACK PHARMACEUTICAL | SEC filing · Form DEFA14A | +0.07% | +0.20% | |
| Form DEFR14A MERRIMACK PHARMACEUTICAL | SEC filing · Form DEFR14A | +0.00% | +0.00% | |
| Form 8-K MERRIMACK PHARMACEUTICAL For: Mar 27 | SEC filing · Form 8-K | +0.10% | +0.07% | |
| Form DEFA14A MERRIMACK PHARMACEUTICAL | SEC filing · Form DEFA14A | +0.10% | +0.07% | |
| Form DEFA14A MERRIMACK PHARMACEUTICAL | SEC filing · Form DEFA14A | +0.00% | -0.07% | |
| Form 10-K/A MERRIMACK PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | +0.03% | +0.20% | |
| Form DEF 14A MERRIMACK PHARMACEUTICAL For: May 10 | SEC filing · Form DEF | +0.03% | +0.20% | |
| Form 10-K MERRIMACK PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.41% | |
| Form 8-K MERRIMACK PHARMACEUTICAL For: Mar 07 | SEC filing · Form 8-K | +0.00% | -0.41% | |
| Form PRE 14A MERRIMACK PHARMACEUTICAL For: Mar 05 | SEC filing · Form PRE | +0.00% | +0.14% | |
| Form 8-K MERRIMACK PHARMACEUTICAL For: Feb 13 | SEC filing · Form 8-K | -0.54% | -0.74% | |
| Form DEFA14A MERRIMACK PHARMACEUTICAL | SEC filing · Form DEFA14A | -0.54% | -0.74% | |
| Form 10-Q MERRIMACK PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.81% | |
| Form 8-K MERRIMACK PHARMACEUTICAL For: Nov 02 | SEC filing · Form 8-K | +0.00% | +0.81% |
Keep exploring
More MACK: earnings → · analyst actions → · MACK overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Nova Leap Health Corp (NLH_CDNX) | 42 | 0.00% | 20% |
| Regional Health Properties, Inc. (RHE) | 42 | +1.71% | 61% |
| PROTOKINETIX INC (PKTX) | 41 | 0.00% | 14% |
| Vascular Biogenics Ltd. - Ordinary Shares (VBLT) | 41 | -4.03% | 0% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.